Is Synairgen PLC halal to invest in?

According to Musaffa's Shariah screening methodology, Synairgen PLC (SNG.L) is currently classified as NOT HALAL as of October 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Synairgen PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Synairgen PLC using these criteria to determine its compliance status.

Can Muslims buy shares of Synairgen PLC?

Muslim investors may consider investing in Synairgen PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Synairgen PLC classified as NOT HALAL?

Musaffa determines the Shariah status of Synairgen PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Synairgen PLC updated?

The Shariah compliance status of Synairgen PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Synairgen PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Synairgen PLC?

You can check the latest Shariah compliance status of Synairgen PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Synairgen PLC SNG.L

£0.95 £0.15 (18.31%) 1D

Last Updated: Apr 08, 12:00 AM·LSE

SNG.L Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 02, 2024

Report Source: 2024 2nd Quarter Report

Analyst's Ratings for Synairgen PLC (SNG.L)

Based on 8 analysts giving stock ratings to Synairgen PLC in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Synairgen PLC. Stock Analysis SNG.L

United Kingdom Health Care Nano Cap Report: Q2, 2024

Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for the treatment and prevention of various viral lung infections in high-risk patient groups. The Company has developed and is testing an inhaled formulation of IFN-B designed to directly target the lungs, the primary site of many viral lung infections, including COVID-19.

Key Statistics of Synairgen PLC (SNG.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

£0.70£1.26

Today's Open

£0.80

Volume

415.54K

P/E Ratio (TTM)

52 Week Range

£0.70£3.00

Market Cap

10.48M

Avg. Volume

1.01M

Dividend Yield

Financial Metrics & Statements of Synairgen PLC (SNG.L)

FAQ's for Synairgen PLC (SNG.L)

According to Musaffa’s Shariah screening methodology, Synairgen PLC (SNG.L) is currently classified as NOT HALAL as of October 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.